This research study is designed to study the combination of two drugs, palbociclib and
ganitumab, as a potential treatment for Ewing sarcoma.
The names of the study drugs involved in this study are:
- Palbociclib
- Ganitumab
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
1 Million 4 Anna Foundation Alan B. Slifka Foundation Carson Sarcoma Foundation ChemoWarrior: the eli sidler foundation i-ROK Foundation Rutledge Cancer Foundation Teaming up to Fight Childhood Cancer